shuttlepharma / Shuttle Pharmaceuticals

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
# Default robots file version:2 User-agent: * Disallow: /calendar/action* Disallow: /events/action* Allow: /.css Allow: /.js Disallow: /*? Crawl-delay:

Meta Tags

Title	Shuttle Pharmaceuticals
Description	Launching the next-generation of Radiation Oncology & Immuno-Oncology Home About us History Management Team Board of Directors Scientific Management Partners and Collaborators Science Overview Science Technology Pipeline Inv
Keywords	N/A

Server Information

WebSite	shuttlepharma.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

shuttlepharma.com Valuation

US$3,282,448

Last updated: 2023-05-18 18:31:12

shuttlepharma.com has Semrush global rank of 3,224,516. shuttlepharma.com has an estimated worth of US$ 3,282,448, based on its estimated Ads revenue. shuttlepharma.com receives approximately 378,744 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, shuttlepharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$3,282,448
Daily Ads Revenue	US$3,030
Monthly Ads Revenue	US$90,899
Yearly Ads Revenue	US$1,090,783
Daily Unique Visitors	25,250
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
shuttlepharma.com.	A	3599	IP: 185.230.63.171
shuttlepharma.com.	A	3599	IP: 185.230.63.186
shuttlepharma.com.	A	3599	IP: 185.230.63.107
shuttlepharma.com.	NS	21600	NS Record: ns1.wixdns.net.
shuttlepharma.com.	NS	21600	NS Record: ns0.wixdns.net.
shuttlepharma.com.	MX	3600	MX Record: 10 mailstore1.secureserver.net.
shuttlepharma.com.	MX	3600	MX Record: 0 smtp.secureserver.net.

HtmlToTextCheckTime:2023-05-18 18:31:12

Home About us History Management Team Board of Directors Scientific Management Partners and Collaborators Science Overview Science Technology Pipeline Investor Relations Press Releases Governance SEC Filings Stock Info Investor Email Alerts Careers Contact Launching the next-generation of Radiation Oncology & Immuno-Oncology treatments Game Changing Potential Shuttle Pharmaceuticals is developing first-in-class therapies that are designed to cure cancer and improve the outcomes of patients receiving radiation therapy. Our focus is on products with unique properties to sensitize cancer cells, protect normal tissues and monitor clinical responses to treatment. Developing a Novel Portfolio We have built a platform technology to advance the discovery and development of novel small molecules to modify the effects of ionizing radiations on cancer cells and normal tissues. To accomplish this goal, we have developed strategic collaborations to leverage programs that include drug discovery,

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Wed, 13 Jul 2022 08:56:19 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.shuttlepharma.com/
strict-transport-security: max-age=3600
Age: 22714
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: jeslxIFvDH4ulYwNNi+3Muwfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVivd4o9HMoDTVPhK7/s60Jl,m0j2EEknGIVUW/liY8BLLlPVSO1QPQ7KlY+JzrfjmCIMbwluI1yUDJty9McxOlfY,2d58ifebGbosy5xc+FRaljOme+0YN84nC4RxCqVmf3/AeYvGtzf7ByEM13DIDd2otHFZHe76OjCYuVYfNGnXHw==,2UNV7KOq4oGjA5+PKsX47IZT0kJPktlWZbg/bPfWvrkfbJaKSXYQ/lskq2jK6SGP
Cache-Control: no-cache
X-Wix-Request-Id: 1657702579.02944424868091213906
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Wed, 13 Jul 2022 08:56:19 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1657702579.2621838075241030550
content-language: en
strict-transport-security: max-age=3600
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMf82wDR9SI4xWdfHsfsHC5A,qquldgcFrj2n046g4RNSVFU+wIjSmTlxqMUV00MvxJE=,2d58ifebGbosy5xc+FRallWXOjfJMRd4YcnWmiGzTEWhe/JbDIv2rM/xGbO36uzU3QpI/ucnHvfrUjeESIoVejiWnK27QgIoHWdaDpHLl3E=,2UNV7KOq4oGjA5+PKsX47IVh8rwr1kfSZp8MOIif7faa46R9xNIlpQ4eUPYpBuqs,7npGRUZHWOtWoP0Si3wDpzSv2KKmODSXUSaql1K+12Y=,kO0u+7q+TL0DeeE//9W7MM7WiLbFsUvGsQ0GMDJXDLYpM3+LPqnPj8vpefTSODh2jvARU2iwro8EBNfbdbrh8g==,xTu8fpDe3EKPsMR1jrheEN5alSttMV20Ztwv/xxQOng=,LoUK8/saGAmOxZWtpubo2qsiaNvLPY/DiTKs75ez01dJHW0peEe+CDmW1UKqYQGxWb3qSj4Chlv0pAAm4k7JSw==,xTu8fpDe3EKPsMR1jrheEFzvgbxa6CM5mPDS4qyf/xg=,xTu8fpDe3EKPsMR1jrheEDevHUCyd/X6/g2cWQZa7Sc=,/a5ccLSK1HEmwPNg/x6OukIT+c5HqyHveWvXmN7dchoxLJHN0oXJet2QBGXo4NLAB/hsMFdkIKLFjWGdCxiyrVsuFMFvifZUPjS86oudvb0=
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=eun1_g; Max-Age=20; Expires=Wed, 13 Jul 2022 08:56:39 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=eun1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"

shuttlepharma.com Whois Information

Domain Name: SHUTTLEPHARMA.COM
Registry Domain ID: 1816575305_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2016-11-07T18:15:55Z
Creation Date: 2013-07-21T12:17:11Z
Registry Expiry Date: 2023-07-21T12:17:11Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS0.WIXDNS.NET
Name Server: NS1.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2022-07-13T09:03:40Z <<<

shuttlepharma.com valuation and analysis